4.5 Article

The mitochondrial T1095C mutation increases gentamicin-mediated apoptosis

Journal

MITOCHONDRION
Volume 12, Issue 4, Pages 465-471

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.mito.2012.06.006

Keywords

Mitochondrial DNA; T1095C; 12SrRNA; Aminoglycosides; Apoptosis; Mitochondrial parkinsonism

Funding

  1. National Health and Medical Research Council (Australia)
  2. Flinders Medical Centre Foundation
  3. Flinders University
  4. Grants-in-Aid for Scientific Research [22240072] Funding Source: KAKEN

Ask authors/readers for more resources

We have previously reported a heteroplasmic mtDNA mutation (T1095C) in the 12SrRNA gene of an Italian family with features of maternally-inherited parkinsonism, antibiotic-mediated deafness and peripheral neuropathy. In the present study, we demonstrate that a transmitochondrial cybrid line derived from the proband of this family shows selective depletion of mitochondrial glutathione and decreases in the activity of complex Moreover, when exposed to an aminoglycoside antibiotic these cells responded with a ten-fold increase in the number of apoptotic cells compared to controls. These results support a pathogenic role for the T1095C mutation and indicate that the mutation increases the risk for aminoglycoside-induced toxicity. (C) 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available